Parkinson Medications A new drug developed to treat Parkinson’s disease showed promising results in people with mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease. Sage Therapeutics, Inc., a biopharmaceutical company, reported that the treatment was generally well-tolerated by participants in Phase 2 of its LUMINARY clinical trial of the neuropsychiatric drug candidate, … Continue reading “Parkinson Medications”
Disclaimer
This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.
